Nori Ebersole
Director/Board Member bij SIENTRA, INC.
Vermogen: 2 980 $ op 31-03-2024
Actieve functies van Nori Ebersole
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
UROVANT SCIENCES LTD. | Human Resources Officer | 01-12-2017 | - |
SIENTRA, INC. | Director/Board Member | 16-07-2021 | - |
Independent Dir/Board Member | 16-07-2021 | - | |
PROMETHEUS BIOSCIENCES, INC. | Human Resources Officer | 01-04-2021 | - |
Big Brothers Big Sisters of Orange County | Director/Board Member | - | - |
Loopbaan van Nori Ebersole
Eerdere bekende functies van Nori Ebersole
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Human Resources Officer | 01-12-2017 | 01-04-2021 |
Paul Hastings LLP
Paul Hastings LLP Miscellaneous Commercial ServicesCommercial Services Paul Hastings LLP engages in the provision of legal services. It specializes in the areas of finance, fintech and payments, mergers and acquisitions, private equity, real state, restructuring, tax advisory, employment law, government, intellectual property, international arbitration, entertainment and media, and technology, media, and telecommunications. The company was founded in 1951 and is headquartered in Los Angeles, CA. | Human Resources Officer | 01-09-2015 | 01-12-2017 |
ALLERGAN PLC | Human Resources Officer | 01-04-1997 | 01-06-2015 |
ALLERGAN, INC. | Human Resources Officer | - | 01-06-2015 |
Opleiding van Nori Ebersole
USC Marshall School of Business | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Ierland | 2 |
Verenigd Koninkrijk | 2 |
Operationeel
Human Resources Officer | 6 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 7 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SIENTRA, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Big Brothers Big Sisters of Orange County | |
Paul Hastings LLP
Paul Hastings LLP Miscellaneous Commercial ServicesCommercial Services Paul Hastings LLP engages in the provision of legal services. It specializes in the areas of finance, fintech and payments, mergers and acquisitions, private equity, real state, restructuring, tax advisory, employment law, government, intellectual property, international arbitration, entertainment and media, and technology, media, and telecommunications. The company was founded in 1951 and is headquartered in Los Angeles, CA. | Commercial Services |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Health Technology |
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Nori Ebersole
- Ervaring